Presented by: Christina M. Wojewoda, MD, FCAP; Linda A. Palicki, MT (ASCP)
Date: Wednesday, July 15, 2015
Most laboratory professionals understand the value of proficiency testing (PT) and have grown to appreciate the confidence in knowing their results are the most accurate for optimum patient care. Despite CAP research that supports that overall PT performance has improved over the years, the Centers for Medicare & Medicaid Services (CMS) continues to place heightened focus on repeat PT failures and the impact of these failures on patient results. This presentation will provide a review of CLIA and CAP PT compliance requirements, including a review of the escalation process up to the most severe of consequences: a directive to cease testing for up to six months for a regulated analyte. Participants will gain valuable knowledge regarding successful investigation practices, including how to determine the level of impact on patient results. Participants will also learn how to develop and implement their own laboratory guidelines supporting the prevention of future laboratory PT failures.